Not if its J&J holding the SP down in order to buy them out later at a lower price.
Its $260 per share and J&J still owns 50% of the drug Imbruvica. PCYC,like GERN, is a one drug company.
Unfortunately a real possibility----no morality in FDA or big pharma.
Their high road is only paved with cashola and greed!
Retail investors are definitely at the back of the line. With GERN
though I dont have to worry about the big boys--I just have to be more patient than most of the smaller investors. This,of course, could take a year or more.
I could possibly have a death wish,though, as i seem to enjoy dancing around in the mine field that IS biotech.
Buyout would be good ,but not the homerun we were looking for. You probably remember SNTS. It seemed to be stuck for months before the buyout by SALIX--
I made good money there but the SP should have been higher than the buyout price IMO.
Good morning Beav--you know we have had absolutely no substance since the Janssen deal.Also
a lot of new faces on the MB are really feces that seem to be here only to misguide and attack the few good ones we have left. I,for one, will have lingering doubts about Janssens intentions until We get some substantial news one way or the other.
New article in Jan.27 issue of Fierce Biotech about Standford University research on telomarese.
It does'nt mention GERN but is overall a positive article concerning things close to home.GLTA
Hello SK , why do you think AKAO may be the most important antibiotic company at the moment.
GET over it Jack! The stock market has been corrupt for well over 100 years-----but--knowing this , you can make a lot of money out here.
Did Dr. Tefferi EVER present any data at ASH-------if he didnt, this silence is SCREAMING at me!!!!!
Seems to be so much going on behind the scenes .
Most retail investors never pick up on institutional sarcasm, which is too bad as more than half the posts
here are quite humorous when seen in the right light.
I guess you guys just never get tired of fishing in the pond.
Sentiment: Strong Buy
Geron is the only biotech to deliver at ASH and not have any followup news----along with the fact that i haven't
heard anything from Dr. Tefferi. IMO they might be sitting on the news until the JNJ deal is signed and JNJ would not even be here if the news wasn't good. The silence says a lot.
Sentiment: Strong Buy